معرفی
Professor Damien Harkin is a Professor in the School of Biomedical Sciences at Queensland University of Technology (QUT), within the Faculty of Health. His roles include academic leadership and research in ocular therapies. He holds honorary positions at the Queensland Eye Institute (since 2005) and Australian Red Cross LifeBlood (since 2020).
Education: BSc and PhD (Pathology) from the University of Adelaide (1993), postdoctoral training at Harvard Medical School (1994-1996) and the University of Melbourne (1997). Earned a Master of Tertiary Education (2019) from the University of Melbourne.
Research Interests: Focuses on cell/tissue therapies for eye diseases, regenerative medicine, biomaterials, and histological techniques. His work has secured over $3M in research funding and led to 80+ publications. Key areas include corneal endothelial cell therapies, silk fibroin-based implants, and ocular surface reconstruction.
Awards: None explicitly listed, but recognized for contributions to academic leadership and digital education transformation. Supervised 7 PhD and 2 Master’s students as principal supervisor. Active in grants, including Australian Competitive Grants for corneal bioengineering and biomaterials.
Labs/Teams: Leads projects in biomaterial development for ocular tissues, collaborating with interdisciplinary teams in QUT and external institutions.
